🔎 Trials Near Me

Akèy › Leksemi limfoblastik egi › Colorado › Denver

Etid klinik pou Leksemi limfoblastik egi nan Denver, CO

7 etid pou Leksemi limfoblastik egi ap chèche patisipan nan sit nan ak bò kote Denver (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • AdventHealth Porter, Denver
Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069

A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)

Ap rekriteFaz 2
  • Colorado Blood Cancer Institute, Denver
6 Months · Tout sèks · Mizajou Sep 28, 2026 · NCT06514794

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Ap rekriteFaz 1/2
  • Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center, Denver
Jiska laj 22 · Tout sèks · Mizajou Aug 25, 2026 · NCT04726241

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Ap rekriteFaz 2
  • Colorado Children's Hospital, Denver
Laj 7 a 25 · Tout sèks · Mizajou Aug 19, 2026 · NCT05082519

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Ap rekriteEtid obsèvasyon
  • Presbyterian St. Luke's/Colorado Blood Cancer Institute, Denver
Tout laj · Tout sèks · Mizajou Jul 6, 2026 · NCT01351545

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Ap rekriteFaz 1/2
  • Colorado Blood Cancer Institute, Denver
Laj 12 ak plis · Tout sèks · Mizajou Mar 24, 2026 · NCT04988555

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Ap rekriteFaz 1
  • Children's Hospital Colorado, Denver
Laj 1 a 21 · Tout sèks · Mizajou Dec 6, 2024 · NCT05476770

Etid Leksemi limfoblastik egi nan lòt vil

Lòt etid nan Denver

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.